Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2221063

CCCCCC(N)N.Cl.Cl

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 known ✓ P35372 1/20 0.60
SPHK1 Q9NYA1 2/20 0.48
DNM1 Q05193 5/20 0.48
TP53 P04637 2/20 0.46
LAP3 P28838 2/20 0.46
CYP2D6 P10635 2/20 0.44
LMNA P02545 2/20 0.44
PLA2G1B P04054 1/20 0.44
PLA2G2A P14555 1/20 0.44
GMNN O75496 1/20 0.44
POLB P06746 1/20 0.44
THPO P40225 1/20 0.44
MTOR P42345 1/20 0.44
BLM P54132 1/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
MAPT P10636 1/20 0.44
CETP P11597 1/20 0.44
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4623132 1.00
Hydrochloric Acid SCHEMBL28931131 0.97 OPRM1 (0.57) OPRM1SPHK1DNM1TP53LAP3
Hydrochloric Acid SCHEMBL30361632 0.97 OPRM1 (0.57) OPRM1SPHK1DNM1TP53LAP3
Hydrochloric Acid SCHEMBL31321294 0.97 OPRM1 (0.57) OPRM1SPHK1DNM1TP53LAP3
Hydrochloric Acid SCHEMBL5193215 0.97 OPRM1 (0.57) OPRM1SPHK1DNM1TP53LAP3
Hydrochloric Acid SCHEMBL28643546 0.97 OPRM1 (0.57) OPRM1SPHK1DNM1TP53LAP3
Hydrochloric Acid SCHEMBL9178287 0.97 OPRM1 (0.57) OPRM1SPHK1DNM1TP53LAP3
SCHEMBL27976138 0.97 OPRM1 (0.63) OPRM1SPHK1DNM1TP53LAP3
SCHEMBL29533 0.97
Hexane SCHEMBL16244743 0.97 OPRM1 (0.63) OPRM1SPHK1DNM1TP53LAP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658695-A1 ISOCYANATE-REACTIVE AND ISOCYANATE-TERMINATED PHOSPHANYLCARBOXAMIDES AND THEIR PRODUCTION AND USE FOR PRODUCING PHOSPHOROUS POLYURETHANES AND POLYISOCYANURATES Covestro Deutschland AG (DE) 2025-12-10 EP disclosed
WO-2024160659-A1 ISOCYANATE-REACTIVE AND ISOCYANATE-TERMINATED PHOSPHANYLCARBOXAMIDES AND THEIR PRODUCTION AND USE FOR PRODUCING PHOSPHOROUS POLYURETHANES AND POLYISOCYANURATES COVESTRO DEUTSCHLAND AG (DE) 2024-08-08 WO disclosed
EP-2513056-B1 CHEMICAL REAGENTS FOR THE ACTIVATION OF POLYSACCHARIDES IN THE PREPARATION OF CONJUGATE VACCINES SERUM INST OF INDIA PVT LTD (IN) 2022-05-04 EP disclosed
CN-108602052-B High charge density metal phosphate molecular sieves 环球油品公司 2021-11-26 CN disclosed
CN-108602054-B High charge density metal phosphate molecular sieves 环球油品公司 2021-09-24 CN disclosed
CN-108602053-B High charge density metal phosphate molecular sieves 环球油品公司 2021-09-24 CN disclosed
CN-108698030-B High charge density metallosilicophosphate molecular sieves 环球油品公司 2021-06-29 CN disclosed
CN-112638825-A Method for making molecular sieves 埃克森美孚研究工程公司 2021-04-09 CN disclosed
US-9259480-B2 Activation of polysaccharides via the cyanylating agent, 1-cyanobenzotriazole (1-CBT), in the preparation of polysaccharide/protein conjugate vaccines FINA BIOSOLUTIONS LLC (US) 2016-02-16 US disclosed
US-9254337-B2 Activation of polysaccharides via the cyanylating agent, 2-cyanopyridazine-3(2H)-one (2-CPO), in the preparation of polysaccharide/protein conjugate vaccines FINA BIOSOLUTIONS, LLC (US) 2016-02-09 US disclosed
EP-0305721-B1 PROCESS FOR PREPARING HEXAMETHYLENE BIS-DICYANIDE DIAMIDE Degussa Aktiengesellschaft (DE) 1991-10-16 EP disclosed
US-5049237-A Organic ammonium ion exchanged ARMSTRONG WORLD INDUSTRIES, INC. (US) 1991-09-17 US disclosed
US-5041655-A Reacting alkali dicyandiamide with hexamethylenediammonium salt in alcohol with controlled amount of water and base catalyst DEGUSSA AKTIENGESELLSCHAFT (DE) 1991-08-20 US disclosed
EP-0435470-A1 Method of immobilizing nucleic acid on a solid surface for use in nucleic acid hybridization assays ORTHO DIAGNOSTIC SYSTEMS INC. (US) 1991-07-03 EP disclosed
US-4990405-A High strength; waterproofing; gasket seals; dielectrics; dielectrics; papers, films, boards and laminates; construction materials ARMSTRONG WORLD INDUSTRIES, INC. (US) 1991-02-05 US disclosed
EP-0387452-A2 Method of preparing nucleotide probes using a hybridizable complementary element ORTHO DIAGNOSTIC SYSTEMS INC. (US) 1990-09-19 EP disclosed
EP-0373956-A2 Nucleotide probes ORTHO DIAGNOSTIC SYSTEMS INC. (US) 1990-06-20 EP disclosed
US-4877484-A ION EXCHANGING TO PROMOTE SWELLING; REACTING WITH DIAMINE ARMSTRONG WORLD INDUSTRIES, INC. (US) 1989-10-31 US disclosed
US-4851021-A Multi-ply composites and sheets of epoxy and flocced 2:1 layered silicates and methods for them ARMSTRONG WORLD INDUSTRIES, INC. (US) 1989-07-25 US disclosed
EP-0305721-A1 Process for preparing hexamethylene bis-dicyanide diamide Degussa Aktiengesellschaft (DE) 1989-03-08 EP disclosed